Related Experiment Videos
[Clinical significance of Willebrand's factor in allergic dermatoses in children]
Insights
Children with allergic dermatoses show increased Willebrand factor (WF) levels, reflecting vascular damage. WF levels decrease with symptom improvement, indicating its role in allergic vasculitis.
Area of Science:
- Pediatric Allergy
- Dermatology
- Vascular Biology
Background:
- Allergic dermatoses involve complex immune responses affecting the skin.
- Vascular endothelium integrity is crucial in inflammatory conditions.
- Willebrand factor (WF) is a key protein in hemostasis and endothelial function.
Purpose of the Study:
- To investigate plasma Willebrand factor (WF) levels in children with allergic dermatoses.
- To correlate WF levels with disease activity and clinical manifestations.
- To assess the potential of WF as a biomarker for allergic vasculitis.
Main Methods:
- Utilized an original micromethod for precise WF content assay.
- Measured WF levels in 45 children during active disease and remission phases.
- Monitored WF levels in relation to the severity of clinical symptoms.
Main Results:
- Children with allergic dermatoses exhibited significantly elevated plasma WF levels.
- Increased WF correlated directly with the severity of clinical manifestations.
- WF levels progressively decreased as clinical symptoms resolved, normalizing upon remission.
- Platelet activation was consistently detected across all forms of allergic dermatoses.
Conclusions:
- Elevated WF in allergic dermatoses reflects systemic vascular endothelium derangement.
- WF normalization signifies the arrest of allergic vasculitis.
- Platelet activation warrants the use of antiplatelet agents in managing these conditions.
Abstract:
An original micromethod for assaying Willebrand's factor (WF) was used to measure the content of the protein in 45 children with different allergic dermatoses. WF measurement were at the height of the clinical manifestations and during remissions. It has been established that children with allergic dermatoses manifest a fairly appreciable increase fo WF in the plasma, which is likely to reflect objectively the systematic nature and gravity of vascular endothelium derangement. The increase of WF correlates with the gravity of the clinical manifestations of the disease. As the clinical symptoms were being removed, the level of WF was progressively decreasing. Its normalization attests to a genuine arrest of allergic vasculitis. Platelet activation detected in all the forms of allergic dermatoses in the basis for inclusion of antiaggregation agents into those patients' treatment.